MSONMISONIX INC

Nasdaq www.misonix.com


$ 25.38 $ 1.20 (4.74 %)    

Wednesday, 27-Oct-2021 15:57:55 EDT
QQQ $ 442.47 $ -0.45 (-0.1 %)
DIA $ 395.44 $ 0.18 (0.05 %)
SPY $ 521.41 $ -0.11 (-0.02 %)
TLT $ 90.33 $ 0.03 (0.03 %)
GLD $ 219.02 $ -0.76 (-0.35 %)
$ 26.54
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 11.04 - $ 26.99
158,811
na
457.18M
$ 1.30
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-02-2021 06-30-2021 10-K
2 05-06-2021 03-31-2021 10-Q
3 02-04-2021 12-31-2020 10-Q
4 11-05-2020 09-30-2020 10-Q
5 09-03-2020 06-30-2020 10-K
6 05-11-2020 03-31-2020 10-Q
7 02-05-2020 12-31-2019 10-Q
8 11-07-2019 09-30-2019 10-Q
9 09-05-2019 06-30-2019 10-K
10 05-08-2019 03-31-2019 10-Q
11 02-06-2019 12-31-2018 10-Q
12 11-08-2018 09-30-2018 10-Q
13 09-13-2018 06-30-2018 10-K
14 05-07-2018 03-31-2018 10-Q
15 02-06-2018 12-31-2017 10-Q
16 11-07-2017 09-30-2017 10-Q
17 08-24-2017 06-30-2017 10-K
18 05-02-2017 03-31-2017 10-Q
19 03-13-2017 09-30-2016 10-Q
20 03-13-2017 12-31-2016 10-Q
21 02-09-2017 06-30-2016 10-K
22 05-05-2016 03-31-2016 10-Q
23 02-09-2016 12-31-2015 10-Q
24 11-05-2015 09-30-2015 10-Q
25 08-20-2015 06-30-2015 10-K
26 05-07-2015 03-31-2015 10-Q
27 02-04-2015 12-31-2014 10-Q
28 11-06-2014 09-30-2014 10-Q
29 09-17-2014 06-30-2014 10-K
30 05-08-2014 03-31-2014 10-Q
31 02-05-2014 12-31-2013 10-Q
32 11-07-2013 09-30-2013 10-Q
33 09-24-2013 06-30-2013 10-K
34 05-10-2013 03-31-2013 10-Q
35 02-07-2013 12-31-2012 10-Q
36 11-06-2012 09-30-2012 10-Q
37 09-20-2012 06-30-2012 10-K
38 05-08-2012 03-31-2012 10-Q
39 02-08-2012 12-31-2011 10-Q
40 11-09-2011 09-30-2011 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 misonix-q4-net-loss-4473m-vs-85m-in-same-qtr-last-year-adj-ebitda-loss-1595m-sales-1968m-up-from-1371m-yoy

Misonix (NASDAQ:MSON) reported $19.68 million in sales this quarter. This is a 43.55 percent increase over sales of $13.71 mill...

 the-daily-biotech-pulse-sanofi-buys-translate-bio-in-32b-deal-lillys-q2-earnings-disappoint-bausch-to-spin-off-medical-aesthetics-business

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 btig-downgrades-misonix-to-neutral

BTIG analyst Ryan Zimmerman downgrades Misonix (NASDAQ:MSON) from Buy to Neutral.

 63-biggest-movers-from-yesterday
63 Biggest Movers From Yesterday
08/02/2021 09:12:40

Gainers

Core News & Articles

Gainers

 craig-hallum-downgrades-misonix-to-hold-raises-price-target-to-28

Craig-Hallum downgrades Misonix (NASDAQ:MSON) from Buy to Hold and raises the price target from $23 to $28.

Core News & Articles

    On Friday morning, 154 companies achieved new highs for the year.

 the-daily-biotech-pulse-erytech-jumps-on-fast-track-designation-glaxosmithkline-fda-nod-alnylams-clinical-collaboration-4-ipos

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 canaccord-genuity-downgrades-misonix-to-hold-raises-price-target-to-28

Canaccord Genuity analyst Kyle Rose downgrades Misonix (NASDAQ:MSON) from Buy to Hold and raises the price target from $23 t...

Core News & Articles

Gainers Atlassian (NASDAQ: TEAM) shares are trading higher after the company reported better-than-expected Q4 EPS and sales ...

 the-daily-biotech-pulse-biogen-faces-another-clinical-setback-curevacs-covid-19-vaccine-study-fails-moment-of-reckoning-for-orphazyme

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION